SCHEDULE 13D/A: Walgreens Boots Alliance Major Shareholder Consolidates Holdings Under Cayman Entity
Beneficial Ownership Update
Stefano Pessina and Alliance Sante Participations S.A. have transferred their entire beneficial ownership of Walgreens Boots Alliance shares to ASP Cayman, a wholly-controlled entity, consolidating 17.1% of the company's common stock.
Summary
- Alliance Sante Participations S.A. (ASP) and Stefano Pessina have transferred all their shares in Walgreens Boots Alliance, Inc. (WBA) to Alliance Sante Participations Ltd. (ASP Cayman).
- ASP sold 144,788,821 shares to ASP Cayman for an aggregate purchase price of $1,594,124,919.21.
- Stefano Pessina sold 832,258 shares to ASP Cayman for an aggregate purchase price of $9,163,160.58.
- The price per share for these transfers was $11.01, based on the Nasdaq closing price on April 25, 2025.
- Payment for these share transfers was made through unsecured promissory notes issued by ASP Cayman to ASP (EUR 1,402,661,609.51) and Stefano Pessina (USD 9,163,160.58).
- As a result of these transfers, ASP and NewCIP II S.a r.l. no longer beneficially own any WBA common stock.
- Stefano Pessina remains the ultimate beneficial owner of 147,615,089 shares, representing approximately 17.1% of WBA's outstanding common stock, primarily through his 100% voting control over ASP Cayman.
- ASP Cayman now directly holds 145,621,079 shares, representing approximately 16.8% of WBA's outstanding common stock.
- The transfers are considered "Permitted Transfers" under existing agreements, and ASP Cayman has entered into joinder agreements to be bound by the terms of the Interim Investors Agreement, Voting Agreement, Reinvestment Agreement, and Company Shareholders Agreement.
Sentiment
Score: 5
Explanation: The document describes an internal restructuring of beneficial ownership, which is a neutral event in terms of company performance. It clarifies the ownership structure without indicating positive or negative operational or financial changes for Walgreens Boots Alliance.
Positives
- Consolidation of significant shareholdings under a single entity (ASP Cayman) simplifies the ownership structure for Stefano Pessina's interests.
- The transaction ensures continuity of existing governance agreements (Voting Agreement, Reinvestment Agreement, Company Shareholders Agreement) through joinder agreements, maintaining stability in shareholder relations.
Risks
- The limitations on disposition and resale of shares are contingent on the consummation of the Merger Agreement; if the merger is not completed, these limitations may be affected.
- The restricted WBA shares (144,539,797 shares) will continue to be endorsed with notations required by the Company Shareholders Agreement, potentially limiting their liquidity.
Future Outlook
The document primarily details a past transaction (April 27, 2025) and its implications for beneficial ownership and existing agreements. It does not provide forward-looking statements or guidance on the company's future performance or strategic direction, beyond the implications of the referenced Merger Agreement.
Industry Context
This filing represents an internal restructuring of a significant shareholder's holdings within a major retail pharmacy and healthcare company. It does not directly reflect broader industry trends or competitive dynamics, but rather a consolidation of control by a key individual within the existing corporate governance framework.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Agreement Joinder | ASP Cayman has agreed to become a party to and be bound by the terms of the Interim Investors Agreement, Voting Agreement, Reinvestment Agreement, and Company Shareholders Agreement through joinder agreements. | 2025-04-27 | Ensures the continuity of existing corporate governance arrangements related to these shareholdings, maintaining stability in shareholder relations and voting control. |
Legal Proceedings
- None of the Reporting Persons or individuals listed in Annex A have been convicted in any criminal proceeding (excluding traffic violations) in the last five years.
- None of the Reporting Persons or individuals listed in Annex A have been a party to a civil proceeding resulting in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws, in the last five years.
Related Party Transactions
- Sale and transfer of 144,788,821 shares of Common Stock from Alliance Sante Participations S.A. (ASP) to Alliance Sante Participations Ltd. (ASP Cayman), where ASP is a subsidiary of NewCIP II, which is owned by ASP Cayman, and ASP Cayman is 100% controlled by Stefano Pessina.
- Sale and transfer of 832,258 shares of Common Stock from Stefano Pessina to Alliance Sante Participations Ltd. (ASP Cayman), where ASP Cayman is 100% controlled by Stefano Pessina.
- Payment for these share transfers was made through unsecured promissory notes issued by ASP Cayman to ASP and Stefano Pessina.
Stakeholder Impact
- Shareholders: The beneficial ownership structure of a significant block of shares has been consolidated under a single entity controlled by Stefano Pessina, providing clarity on control. No change in the total number of outstanding shares.
- Creditors: ASP Cayman has incurred debt via promissory notes to finance the share acquisition, which could impact its financial structure, though this is an internal transaction.
Next Steps
- ASP Cayman will file future amendments to Schedule 13D under its own CIK number as a Reporting Person.
- The shares underlying Stefano Pessina's restricted stock units are scheduled to vest on November 1, 2025, November 1, 2026, and November 1, 2027.
- The shares underlying Ornella Barra's restricted stock units are scheduled to vest on November 1, 2025, November 1, 2026, and November 1, 2027.
- The shares subject to Ornella Barra's performance share awards are scheduled to vest on November 1, 2025, and November 1, 2027.
- The promissory notes issued by ASP Cayman are due to mature on April 27, 2030.
Key Dates
| Date | Description |
|---|---|
| 2012-08-02 | Original Company Shareholders Agreement date. |
| 2014-12-31 | Original Schedule 13D filing date by Reporting Persons. |
| 2015-01-20 | Amendment No. 1 to Schedule 13D filed. |
| 2015-12-31 | Amendment No. 2 to Schedule 13D filed. |
| 2016-11-04 | Amendment No. 3 to Schedule 13D filed. |
| 2018-01-17 | Amendment No. 4 to Schedule 13D filed. |
| 2018-07-17 | Amendment No. 5 to Schedule 13D filed. |
| 2019-11-05 | Amendment No. 6 to Schedule 13D filed. |
| 2019-12-17 | Amendment No. 7 to Schedule 13D filed; date of Prior Joint Filing Agreement. |
| 2020-07-27 | Amendment No. 8 to Schedule 13D filed. |
| 2025-03-06 | Date of Voting Agreement, Reinvestment Agreement, Interim Investors Agreement, and Merger Agreement. |
| 2025-03-07 | Amendment No. 9 to Schedule 13D filed. |
| 2025-04-01 | Date as of which 864,737,898 shares of Common Stock were outstanding, as reported in the Issuer's Form 10-Q. |
| 2025-04-08 | Issuer's Quarterly Report on Form 10-Q for period ended February 28, 2025 filed with SEC. |
| 2025-04-25 | Last trading day before the share sale; Nasdaq closing price of $11.01 per share used for transaction valuation; Exchange rate of 1.1365 EUR/USD quoted at 4:00 p.m. EDT. |
| 2025-04-27 | Date of event requiring filing of this statement; Effective date of share purchase agreements (ASP SPA, Pessina SPA) and joinder agreements (IIA, VA, RA, SHA); ASP and NewCIP II ceased beneficial ownership. |
| 2025-04-28 | Trading day immediately preceding the date of this Amendment; closing price of US$10.96. |
| 2025-04-29 | Date of filing of Amendment No. 10 and Joint Filing Agreement. |
| 2025-11-01 | Vesting date for 207,039 shares (plus 35,644 dividend shares) of Pessina's restricted stock units; Vesting date for 206,331 shares (plus 15,364 dividend shares) of Ornella Barra's restricted stock units; Vesting date for 58,230 shares of Ornella Barra's performance share awards. |
| 2025-11-27 | End date for initial Applicable Rate of 2.821% per annum for ASP Promissory Note. |
| 2026-11-01 | Vesting date for 374,883 shares (plus 39,742 dividend shares) of Pessina's restricted stock units; Vesting date for 187,141 shares (plus 12,043 dividend shares) of Ornella Barra's restricted stock units. |
| 2027-11-01 | Vesting date for 641,711 shares (plus 18,525 dividend shares) of Pessina's restricted stock units; Vesting date for 101,361 shares (plus 2,926 dividend shares) of Ornella Barra's restricted stock units; Vesting date for 303,476 shares (plus 8,761 dividend equivalent units) of Ornella Barra's performance share awards. |
| 2030-04-27 | Maturity Date for both ASP and Pessina Promissory Notes (fifth anniversary of the notes' date). |
Keywords
Walgreens Boots Alliance, WBA, SEC Filing, Schedule 13D/A, Beneficial Ownership, Share Transfer, Stefano Pessina, ASP Cayman, Alliance Sante Participations, Corporate Governance, Shareholder Agreement, Promissory Note, Investment Holdings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.